Pancreatic Cancer Research

ResearcherShandong UniversityActive in the last 2 years

Chengqing Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5385-7644; OpenAlex author ID A5089601494. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper

Papers 2

  1. Evaluating the benefits of adjuvant chemotherapy in patients with pancreatic cancer undergoing radical pancreatectomy after neoadjuvant therapy-a systematic re… Co-author DOI 10.3389/fonc.2024.1429386↗
  2. Fibrinogen-to-prealbumin ratio: A new prognostic marker of resectable pancreatic cancer. Co-author DOI 10.3389/fonc.2023.1149942↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lei Wang · 2 shared papers, 2023–2024 · strength 0.37
  2. Jianwei Xu · 1 shared paper, 2024 · strength 0.21
  3. Jiahao Wu · 1 shared paper, 2024 · strength 0.21
  4. Wenyi Guo · 1 shared paper, 2023 · strength 0.17
  5. Jianwei Xu · 1 shared paper, 2023 · strength 0.17
  6. Feng Li · 1 shared paper, 2023 · strength 0.17
  7. Zhiyao Fan · 1 shared paper, 2023 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.